Perpetual Ltd Has $21.61 Million Holdings in Koninklijke Philips N.V. (NYSE:PHG)

Perpetual Ltd cut its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 22.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 850,748 shares of the technology company's stock after selling 249,815 shares during the quarter. Perpetual Ltd owned approximately 0.09% of Koninklijke Philips worth $21,609,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PHG. Connor Clark & Lunn Investment Management Ltd. lifted its position in Koninklijke Philips by 87.7% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company's stock worth $56,266,000 after buying an additional 1,038,321 shares in the last quarter. Northern Trust Corp lifted its position in Koninklijke Philips by 36.6% during the 4th quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company's stock worth $40,734,000 after buying an additional 430,757 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Koninklijke Philips during the 4th quarter worth about $10,655,000. GAMMA Investing LLC lifted its position in Koninklijke Philips by 3,094.8% during the 1st quarter. GAMMA Investing LLC now owns 350,241 shares of the technology company's stock worth $8,896,000 after buying an additional 339,278 shares in the last quarter. Finally, Causeway Capital Management LLC lifted its position in Koninklijke Philips by 24.0% during the 4th quarter. Causeway Capital Management LLC now owns 1,566,850 shares of the technology company's stock worth $39,673,000 after buying an additional 303,428 shares in the last quarter. 13.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on PHG shares. Wall Street Zen cut shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Sunday, June 15th. Sanford C. Bernstein raised shares of Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, March 18th. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy".

Koninklijke Philips Stock Performance

Shares of PHG stock traded down $0.15 on Monday, reaching $23.99. The stock had a trading volume of 614,444 shares, compared to its average volume of 896,300. Koninklijke Philips N.V. has a 12 month low of $20.61 and a 12 month high of $31.57. The firm has a market capitalization of $23.10 billion, a price-to-earnings ratio of 55.79, a P/E/G ratio of 0.68 and a beta of 0.76. The firm's 50-day moving average is $23.73 and its two-hundred day moving average is $25.03. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 0.60.

Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.14 by $0.13. Koninklijke Philips had a return on equity of 10.97% and a net margin of 2.11%. The company had revenue of $4.31 billion during the quarter, compared to analysts' expectations of $4.10 billion. During the same quarter in the previous year, the company posted $0.21 earnings per share. The business's revenue was down 1.0% on a year-over-year basis. On average, research analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.